YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vytorin
FDA Planning Hiring Blitz
May 1, 2008 | Parker Waichman Alonso LLP
The beleaguered Food & Drug Administration (FDA) is planning on filling over 1,300 positions by the end of September, triple the amount hired by...
FDA Considering Biomarkers As a Way to Improve Drug Safety
Apr 17, 2008 | Parker Waichman Alonso LLP
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up...
Vytorin Investigation Focuses on Minutes of November Meeting
Apr 14, 2008 | Parker Waichman Alonso LLP
Lawmakers probing Vytorin have discovered that Merck and Schering-Plough had minutes of a key meeting about the drug written weeks after the event...
FDA Official Says Agency Won't Take Sides on Vytorin - Then Defends Vytorin
Apr 11, 2008 | Parker Waichman Alonso LLP
Criticism of Vytorin is unfair, a Food & Drug Administration (FDA) official said this week. However, CDER director Janet Woodcock said the...
New Vytorin Orders Fall
Apr 10, 2008 | Parker Waichman Alonso LLP
New prescriptions for Vytorin were down last week, following last month's recommendations from some top cardiologists that Vytorin be used only as a...
High Profile Drugs Turn Out to be Duds
Apr 7, 2008 | Parker Waichman Alonso LLP
Millions of Vytorin users recently learned that Vytorin and its component drug, Zetia, failed to work as initially expected. Final results of a...
UnitedHealth Group Says it Will Still Cover Vytorin
Apr 4, 2008 | Parker Waichman Alonso LLP
Vytorin coverage will not change for people enrolled in health plans provided by UnitedHealth Group. The nation's largest health insurer said...
Insurers Taking Another Look at Vytorin Coverage
Apr 2, 2008 | Parker Waichman Alonso LLP
Insurers are said to be reconsidering coverage for Vytorin, after a study showed the cholesterol-lowering drug provided no added benefits over...
Vytorin Emails Raise Questions About ENHANCE Delay
Apr 1, 2008 | Parker Waichman Alonso LLP
The Vytorin fallout continues, with one lawmaker demanding that Vytorin's makers explain why the results of a crucial study were delayed for more...
Vytorin Should be Considered a "Last Resort"
Mar 31, 2008 | Parker Waichman Alonso LLP
Vytorin should only be used as a last resort because there is no evidence that the cholesterol-lowering medication provides any more benefits than...
Vytorin
